MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Vedanta in talks to raise up to $3bn debt in semiconductors push.
You can access today’s complete newsletter?here.
Scroll down for more…
Jim Ratcliffe, INEOS Chairman and CEO, offered to acquire Chelsea FC, an English professional football club, from Roman Abramovich for ￡4.25bn ($5.34bn).
"We believe that a club is bigger than its owners who are temporary custodians of a great tradition. With responsibility to the fans and the community. We will invest in Stamford Bridge to make it a world-class stadium, befitting of Chelsea FC. This will be organic and on-going so that we will not move away from the home of Chelsea and risk losing the support of loyal fans. We will continue to invest in the team to ensure we have a first class squad of the world’s greatest players, coaches and support staff, in the men’s and women’s games," Jim Ratcliffe, INEOS Chairman.
Perrigo, a firm providing over-the-counter self-care and wellness solutions, completed the acquisition of HRA Pharma, a consumer healthcare company, from investment firms Astorg and Goldman Sachs Asset Management for $1.9bn.?
"With the addition of HRA and its talented leadership team, Perrigo would be a consumer self-care global leader that is poised to deliver top tier net sales growth and double-digit EPS growth in the near-term while concurrently expanding margins. The complementary geographic footprint of HRA to that of Perrigo would allow for significant and actionable synergies. And it is the totality of these factors that makes the combination of Perrigo and HRA strategically and financially compelling. It's literally a one-of-a-kind opportunity to simultaneously enhance our financial profile, while driving even greater value for consumers, shareholders and the communities in which we work and live," Murray S. Kessler, Perrigo CEO and President.
Perrigo was advised by Centerview Partners, Darrois Villey Maillot Brochier, Wachtell Lipton Rosen & Katz and Brunswick Group. Centerview Partners was advised by Gibson Dunn & Crutcher. HRA Pharma was advised by Dechert. Goldman Sachs Asset Management was advised by Goldman Sachs, Rothschild & Co, Sawaya Capital, Latham & Watkins and Sullivan & Cromwell.
Sandstorm Gold, a provider of financing to companies engaged in gold mining, agreed to acquire Nomad Royalty, a gold & silver royalty company, for $590m and nine royalties and one stream from BaseCore Metals, an operator of an asset investment vehicle, for $525m.
"These transactions mark the next step in the strategic growth plans for Sandstorm. Today's announcement propels the Company forward in both size and scale while solidifying Sandstorm's position amongst its peers as the highest-growth streaming and royalty company. We believe that precious metals and copper are poised to materially outperform the market in the coming years, and we are excited to provide investors with exposure to long-life, high quality, and low-cost assets focused on gold, silver and copper," Nolan Watson, Sandstorm Gold President & CEO.
Sandstorm Gold is advised by BMO Capital Markets, Fort Capital Partners, Cassels Brock & Blackwell and Neal Gerber & Eisenberg.
Sema4, an AI-driven genomic and clinical data intelligence platform company, completed the acquisition of GeneDx, a provider of genomic testing and analysis, from OPKO Health, a multinational biopharmaceutical and diagnostics company, for $623m.
"This acquisition gives us the opportunity to accelerate the use of genomics as standard of care by providing a deeper menu of precision medicine solutions to our health system partners to better meet their clinical needs," Eric Schadt, Sema4 Founder and CEO.
Sema4 was advised by BTIG, Goldman Sachs, Jefferies & Company and Fenwick & West. OPKO Health was advised by Cowen & Company, JP Morgan, Greenberg Traurig and LHA Investor Relations.
Vedanta in talks to raise up to $3bn debt in semiconductors push.?
Vedanta, a global diversified mining company, is in talks with banks to raise debt of $2.5-$3bn to bolster its semiconductor and display manufacturing plans,?DealStreetAsia?reported.
"We have financial banking relationships across India. We are talking to them," Akarsh Hebbar, Vedanta Global Managing Director of Display and Semiconductor Business.
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.